Jonathan Fusco
Process Industrialization Project Manager at Debiopharm - Lausanne, Vaud, Switzerland
Jonathan Fusco's Colleagues at Debiopharm
Simona Abbatemarco
Scientific Fellow in Clinical Safety and Pharmacovigilance
Jonathan Fusco's Contact Details
["+20 190612900080","+592 20130117"]
Martigny,Valais,Switzerland
Debiopharm
Jonathan Fusco's Company Details
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners to maximize patient access across the globe. Debiopharm International SA focuses on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide. Debiopharm completed the development and licensed out 2 compounds:- Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl®-Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®If you have interesting molecules and seek a competent and committed partner to develop them, please contact us.